Sources | Names Used |
---|---|
CTRPv2 | BRD-K11533227 |
PharmacoGx | BRD-K11533227 |
Database | Identifier |
---|---|
Smiles: | -666 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NTN5 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | ATPAF1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | HLA-DQA2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | EYA1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | VSTM2B | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | TRMT112 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | EFR3A | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | MAP3K14 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | LMF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RAD51L3-RFFL | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |